Early research (Phase 1)Study completedNCT04943900What this trial is testingBMS-986416 With and Without Nivolumab in Select Solid TumorsWho this might be right forAdvanced Solid Tumors Bristol-Myers Squibb 67
Early research (Phase 1)Looking for participantsNCT06043466What this trial is testingA Clinical Trial Targeting CEA Chimeric Antigen Receptor T (CAR-T) for CEA Positive Advanced Malignant Solid TumorsWho this might be right forColorectal CancerEsophagus CancerGastric Cancer+4 more Chongqing Precision Biotech Co., Ltd 30
Testing effectiveness (Phase 2)Ended earlyNCT04165031What this trial is testingLY3499446 in Participants With Advanced Solid Tumors With KRAS G12C MutationWho this might be right forAdvanced Solid TumorNon-Small Cell Lung CancerColorectal Cancer Eli Lilly and Company 5
Testing effectiveness (Phase 2)Study completedNCT05597839What this trial is testingStudy of DF9001 in Patients With Advanced Solid TumorsWho this might be right forSolid Tumor, Adult Dragonfly Therapeutics 24
Early research (Phase 1)Looking for participantsNCT07540572What this trial is testingInvestigate the Safety, Pharmacokinetics, and Preliminary Efficacy of IDE574 Therapy in Adult Participants With Advanced Solid TumorsWho this might be right forER+, HER 2- Breast CancerNon-small Cell Lung Cancer (NSCLC)Castration-resistant Prostate Cancer (CRPC)+1 more IDEAYA Biosciences 160
Early research (Phase 1)Looking for participantsNCT04777994What this trial is testingStudy With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic TumorsWho this might be right forAdvanced Solid Tumor Cancer Calico Life Sciences LLC 248
Early research (Phase 1)Study completedNCT02595866What this trial is testingTesting the Addition of an Experimental Medication MK-3475 (Pembrolizumab) to Usual Anti-Retroviral Medications in Patients With HIV and CancerWho this might be right forAIDS-Related Non-Hodgkin LymphomaClinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8+16 more National Cancer Institute (NCI) 58
Early research (Phase 1)Active Not RecruitingNCT02988960What this trial is testingABBV-927 and ABBV-181, an Immunotherapy, in Participants With Advanced Solid TumorsWho this might be right forAdvanced Solid Tumors Cancer AbbVie 163
Testing effectiveness (Phase 2)Ended earlyNCT00004159What this trial is testingGemcitabine Plus Paclitaxel in Treating Patients With Advanced Non-small Cell Lung Cancer or Other Solid TumorWho this might be right forLung Cancer University of Alabama at Birmingham 54
Early research (Phase 1)Ended earlyNCT03957096What this trial is testingA Safety Study of SGN-CD47M in Patients With Solid TumorsWho this might be right forSoft Tissue SarcomaColorectal CancerHead and Neck Squamous Cell Carcinoma+6 more Seagen Inc. 16
Early research (Phase 1)Study completedNCT00020579What this trial is testingMS-275 in Treating Patients With Advanced Solid Tumors or LymphomaWho this might be right forCancer National Institutes of Health Clinical Center (CC) 75
Testing effectiveness (Phase 2)Ended earlyNCT05714553What this trial is testingNUC-3373 in Combination With Other Agents in Patients With Advanced Solid TumoursWho this might be right forAdvanced CancerAdvanced Solid TumorNeoplasm Malignant+14 more NuCana plc 19
Testing effectiveness (Phase 2)Ended earlyNCT04260802What this trial is testingEvaluate the Safety and Pharmacokinetics of OC-001 in Patients With Locally Advanced or Metastatic CancersWho this might be right forCancerNeoplasmsMetastatic Cancer+16 more Ocellaris Pharma, Inc. 73
Early research (Phase 1)Looking for participantsNCT06625775What this trial is testingOpen-Label Study of BBO-10203 in Subjects With Advanced Solid TumorsWho this might be right forSolid Tumor, AdultMetastatic Breast CancerAdvanced Breast Cancer+8 more TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics) 392
Early research (Phase 1)UnknownNCT02637531What this trial is testingA Dose-Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of IPI-549Who this might be right forAdvanced Solid Tumors (Part A/B/C/D)Non-small Cell Lung Cancer (Part E)Melanoma (Part E)+5 more Infinity Pharmaceuticals, Inc. 219
Early research (Phase 1)Study completedNCT04374877What this trial is testingStudy of CHS-388 (Formerly Known as SRF388) in Patients With Advanced Solid TumorsWho this might be right forAdvanced Solid TumorClear Cell Renal Cell CarcinomaHepatocellular Carcinoma+1 more Coherus Oncology, Inc. 145
Early research (Phase 1)Study completedNCT00019019What this trial is testingCarboxyamidotriazole and Paclitaxel in Treating Patients With Advanced Solid Tumors or Refractory LymphomasWho this might be right forBrain and Central Nervous System TumorsBreast CancerKidney Cancer+6 more National Institutes of Health Clinical Center (CC) 70
Early research (Phase 1)Active Not RecruitingNCT02321501What this trial is testingCeritinib and Everolimus in Treating Patients With Locally Advanced or Metastatic Solid Tumors or Stage IIIB-IV Non-small Cell Lung CancerWho this might be right forALK PositiveLocally Advanced Malignant Solid NeoplasmMetastatic Malignant Solid Neoplasm+3 more M.D. Anderson Cancer Center 37
Early research (Phase 1)Ended earlyNCT05061537What this trial is testingStudy of PF-07263689 in Participants With Selected Advanced Solid TumorsWho this might be right forRenal Cell CancerMelanomaNon-Small-Cell Lung Cancer+7 more Pfizer 13
Early research (Phase 1)Study completedNCT03096054What this trial is testingA Phase I Trial of LY3143921 Hydrate in Solid TumoursWho this might be right forColorectal CancerHigh Grade Serous Ovarian CancerNon Small-cell Lung Cancer (Squamous Cell Variant)+4 more Cancer Research UK 69